References
[1] Strengers, P. F. W. (2023). Challenges for plasma-derived medicinal products. Transfusion Medicine and Hemotherapy, 50(2), 116–122. https://doi.org/10.1159/000528959
[2] Olaniyan, M. F., & Muhibi, M. A. (2023). Plasma-derived medicinal products in Nigeria. SN Comprehensive Clinical Medicine, 5(1). https://doi.org/10.1007/s42399-023-01527-8
[3] Burnouf, T. (2018). An overview of plasma fractionation. Annals of Blood, 3, 33–33. https://doi.org/10.21037/aob.2018.05.03
[4] Burnouf, T. (2007). Modern Plasma Fractionation. Transfusion Medicine Reviews, 21(2), 101–117. https://doi.org/10.1016/j.tmrv.2006.11.001
[5] Burnouf, T. (1995). Chromatography in plasma fractionation: Benefits and future trends. Journal of Chromatography B: Biomedical Sciences and Applications, 664(1), 3–15. https://doi.org/10.1016/0378-4347(94)00532-a
[6] Al-Haj Ibrahim, H. (2019). Introductory chapter: Fractionation. Fractionation. https://doi.org/10.5772/intechopen.78050
[7] Featherstone, P. J., & Ball, C. M. (2023). The development of albumin solutions in the Second World War. Anaesthesia and Intensive Care, 51(4), 236–238. https://doi.org/10.1177/0310057×231174704
[8] Kaur, J. (2023, May 8). Fibrinogen. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK537184/
[9] Lopez, M. J. (2023, May 22). Thrombin. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK557836/
[10] Azar, A. (2021, October 29). IGG deficiencies. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/igg-deficiencies
[11] Novaretti, M. C., & Dinardo, C. L. (2011). Immunoglobulin. Revista Brasileira de Hematologia e Hemoterapia, 33(5), 377–382. https://doi.org/10.5581/1516-8484.20110102
[12] Tanaka, K., Shigueoka, E. M., Sawatani, E., Dias, G. A., Arashiro, F., Campos, T. C. X. B., & Nakao, H. C. (1998). Purification of human albumin by the combination of the method of cohn with liquid chromatography. Brazilian Journal of Medical and Biological Research, 31(11), 1383–1388. https://doi.org/10.1590/s0100-879×1998001100003
[13] Harris, J. R. (1991). Blood separation and plasma fractionation. Wiley-Liss.
[14] Siew, A. (n.d.). Impurity testing of biologic drug products. BioPharm International. https://www.biopharminternational.com/view/impurity-testing-0
[15] Johnston, A., & Adcock, W. (2000). The use of chromatography to manufacture purer and safer plasma products. Biotechnology and Genetic Engineering Reviews, 17(1), 37–70. https://doi.org/10.1080/02648725.2000.10647987